Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Spectrum disorder of neuromyelitis optica in a patient presenting with intractable vomiting and hiccups, transverse myelitis and acute encephalopathy.
Risk Factors Associated with the Onset of Relapsing-Remitting and Primary Progressive Multiple Sclerosis: A Systematic Review.
Endogenous opioid inhibition of proliferation of T and B cell subpopulations in response to immunization for experimental autoimmune encephalomyelitis.
Diet, microbiota and autoimmune diseases.
Impact of Autologous Mesenchymal Stem Cell Infusion on Neuromyelitis Optica Spectrum Disorder: A Pilot, 2-Year Observational Study.
An assay to quantify species-specific anti-JC virus antibody levels in MS patients.
Deep gray matter demyelination detected by magnetization transfer ratio in the cuprizone model.
Low vitamin D level is associated with higher relapse rate in natalizumab treated MS patients.
Minocycline Hydrochloride (1818)
Doubly selective multiple quantum chemical shift imaging and T(1) relaxation time measurement of glutathione (GSH) in the human brain in vivo.
Disruption of melatonin circadian rhythm production is related to multiple sclerosis severity: A preliminary study.
Simvastatin as an Add-on Treatment to Interferon-beta-1a for the Treatment of Relapsing-Remitting Multiple Sclerosis (SIMCOMBIN)
Safety and efficacy of natalizumab in Belgian multiple sclerosis patients: subgroup analysis of the natalizumab observational program.
Cerebral white matter blood flow and energy metabolism in multiple sclerosis.
Long-Term Neurocognitive, Psychosocial, and Magnetic Resonance Imaging Outcomes in Pediatric-Onset Acute Disseminated Encephalomyelitis.
Neuromyelitis optica in children: a review of the literature.
Method for the systematic reviews on occupational therapy and neurodegenerative diseases.
Regulatory T cells and Th17 cells in viral infections: implications for multiple sclerosis and myocarditis.
Hematopoietic mobilization: Potential biomarker of response to natalizumab in multiple sclerosis.
Estimation and partitioning of polygenic variation captured by common SNPs for Alzheimer's disease, multiple sclerosis and endometriosis.
[Coping with multiple sclerosis in partnerships : A systematic review of the literature.]
Transcriptomic profile reveals gender-specific molecular mechanisms driving multiple sclerosis progression.
Predictive value of early serum cytokine changes on long-term interferon beta-1a efficacy in multiple sclerosis.
Massage therapy and exercise therapy in patients with multiple sclerosis: a randomized controlled pilot study.
Symptomatic correlates of six-minute walk performance in persons with multiple sclerosis.
Pages
« first
‹ previous
…
270
271
272
273
274
275
276
277
278
…
next ›
last »